SCHEMBL7724837

SCHEMBL7724837

C=CCc1cccc2nc(Cc3ccccc3Cl)oc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 2/20 0.41
KDM4E B2RXH2 4/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
C1R P00736 1/20 0.39
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
MAP4K4 O95819 1/20 0.37
RET P07949 1/20 0.37
IGF1R P08069 1/20 0.37
MET P08581 1/20 0.37
PIM1 P11309 1/20 0.37
LTK P29376 1/20 0.37
KDR P35968 1/20 0.37
MAPK8 P45983 1/20 0.37
MAPK9 P45984 1/20 0.37
CDK8 P49336 1/20 0.37
CLK2 P49760 1/20 0.37
CDK9 P50750 1/20 0.37
CDK5 Q00535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7733885 0.86 ESR1 (0.39) PTK2KDM4EMAPTLMNAALDH1A1
SCHEMBL8789080 0.82 PARP14 (0.41) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL7733869 0.78 MTNR1A (0.46) PTK2MTNR1AMTNR1B
SCHEMBL7734817 0.72 MEN1 (0.41) MAPTLMNAALDH1A1SMN1; SMN2GAA
SCHEMBL7737657 0.72 MTNR1A (0.43) MTNR1AMTNR1B
SCHEMBL248417 0.71 IDO1 (0.50) LMNAALDH1A1SMN1; SMN2PKM
SCHEMBL29473927 0.71 IDO1 (0.50) LMNAALDH1A1SMN1; SMN2PKM
SCHEMBL7724834 0.69 L3MBTL1 (0.39) PTK2KDM4EMAPTLMNAC1R
Hydrochloric Acid SCHEMBL11666235 0.69 IDO1 (0.48) LMNAALDH1A1SMN1; SMN2PKM
SCHEMBL9275883 0.69 IDO1 (0.48) LMNAALDH1A1SMN1; SMN2PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed